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Abstract 
 
Introduction 
The year 2015, represented the target year for the Millennium Development Goals (MDGs). 
However, the MDG target could not be achieved in most countries. The World Health 
Organization (WHO) estimated that of 56 million global deaths in 2012, 38 million, or 68%, 
were due to non-communicable diseases (NCDs). The four main NCDs are cardiovascular 
disease, cancer, diabetes and chronic lung disease.2 Most of these conditions are 
preventable through public health initiatives involving community pharmacists. This study 
aims to identify strategies enhancing the public health role of community pharmacists. 
 
Methods 
Data was collected through telephone interviews, supported by Skype, and recorded using 
the 'HD Call Recorder for Skype'. The qualitative data software package NVivo (version 10) 
was used for the storage, retrieval and analysis of data. The constant comparative method 
of data analysis was used.  
 
Results 
Participants suggested a number of strategies to enhance the public health role of 
community pharmacists in the UK. They included: integrating UK undergraduate healthcare 
programmes; broadening the public health knowledge of students and pharmacists; 
pharmacists working alongside other healthcare professionals; teaching communication 
methods to students and pharmacists; teaching the use of new technologies and social 
media; empowerment through the direct remuneration of pharmacists; and creating greater 
awareness of the public health role of the community pharmacist. Enhancing the public 
health role of community pharmacists could make services more accessible to the public, 
enhance public safety and trust in pharmacists, encourage collaboration between 
pharmacists, doctors and other healthcare providers, as well as, bring financial savings to 
the NHS 
 
Conclusions 
This study has identified strategies that could potentially enhance the public health role of 
community pharmacists in the UK. Enhancing the public health role of community 
pharmacists could make services more accessible to the public, improve public safety and 
trust in pharmacists, encourage collaboration between pharmacists, doctors and other 
healthcare providers, as well as bringing financial savings to the NHS. 
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Strategies enhancing the public health role of community pharmacists – A 
qualitative study  
 
Introduction 
According to the WHO,1 2015 represented the target year for the Millennium Development 
Goals (MDGs). However, as some of the gains made in different regions of the world have 
been uneven, this has meant that the MDG target could not be achieved in most countries1 
The WHO also estimated that of 56 million global deaths in 2012, 38 million, or 68%, were 
due to non-communicable diseases.2 The four main NCDs are cardiovascular disease, cancer, 
diabetes and chronic lung disease.2 Most of these conditions are preventable through public 
health initiatives involving community pharmacists. 
 
In the UK, the government has identified the importance of a multidisciplinary public health 
workforce for handling the main causes of ill health.3,4 In a recent White Paper, 'Five Year 
Forward View', the UK government presented its plan to make greater use of pharmacists 
through its Multi-specialty Community Providers (MCPs), who would become the focal point 
for a far wider range of care needed by their registered patients.5 The vision outlined in the 
White Paper is also supported by the findings of a recent study,6 and cited by another 
paper,7 which reported that the cost of treating common ailments (e.g. head lice, 
threadworms, athlete’s foot, etc.) in community pharmacies was about £29.30 per patient. 
However, when the same ailments were treated at A&E, the cost was found to be nearly 
five times higher at £147.09 per patient and nearly three times higher at GP practices at 
£82.34 per patient.7 
 
Aim: To identify strategies enhancing the public health role of community pharmacists. 
 
Method 
Design 
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The sample size for the study was determined during the process, hence, the interviews 
were continued until no new information was yielded or data became saturated.8,9 
Individual participants were randomly selected based on their availability and willingness to 
participate in the study. Informed consent was obtained from participants prior to inclusion 
in the study. Data was collected through telephone interviews, supported by Skype, using an 
interview guide that incorporated open-ended questions.10 Interviews were recorded with 
HD Call Recorder for Skype, and lasted approximately 20–30 minutes. These interviews were 
facilitated by members of the research team: CA conducted the in-depth interviews, 
consistent with the method suggested for such  interviews.11 Researchers JO and JP 
reviewed the potential topics to determine their suitability.12 Participants were assured that 
confidentiality was guaranteed.13 
 
Analysis 
The qualitative data software package NVivo (version 10) was used for the storage, retrieval 
and analysis of data. CA transcribed the interviews verbatim. An experienced researcher as a 
validity check on the interpretative process independently verified the coding procedure. In 
the analysis, the constant comparative method was used,14 and processes adapted from 
other researchers15,16 were applied to code the data. Initial codes were assigned to data that 
was of interest to the analytical framework through a process of repeated reading, the 
emphasis being on including all relevant data. As the analysis progressed, the number of 
new codes reached saturation point, with the process of refinement then taking 
precedence. The codes were considered together to identify patterns and connections to 
form what became subcategories, which were then connected across higher order 
categories.17 Emerging themes were reviewed for counterthemes18 In addition, some 
numerical data were presented in the analysis.19 
 
Results 
Characteristics of healthcare professionals interviewed 
In terms of characteristics, fifteen healthcare professionals (including eleven pharmacists, 
three General Practitioners and a nurse) were included in the interviews. Nine (60%) of the 
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healthcare professionals interviewed were female and the majority of participants (seven 
(46.7%)) were aged between 50 and 59 years. Following the telephone interviews with 
healthcare professionals, a number of themes emerged from the data analysis. 
Enhancing the public health role of community pharmacists in the UK 
Participants suggested a number of strategies needed to enhance the public health role of 
community pharmacists in the UK. 
Empowerment through education and awareness 
Two pharmacists who felt that little could be achieved without the support of these very 
important groups highlighted the wider issue of empowerment by the public and the 
commissioning and regulatory bodies. For one participant, enhancing the undergraduate 
and postgraduate training/awareness of pharmacists in clinical skills as well as public health 
was important, 
But I feel that for the public to trust us more, I think we need to really do more 
clinical stuff, during our undergraduate training or even post-graduation (PR-FLY). 
 
At least two other participants highlighted the need to create more awareness and develop 
the public health training of pharmacists. One of these participants, a pharmacist, also 
suggested that pharmacists should also work with other healthcare professionals. Two GPs 
talked about the need for public awareness and a referral system, with the overall impact 
being that this could help minimise the present wastage of NHS resources, 
I think making access better. It is very difficult to get hold of anybody. I think to save 
the GPs extra work by making sure that the pharmacists can give initial advice … 
Maybe the government should try to do it, to raise awareness that you should go to 
you [pharmacist] first, and not your GP (GP partner-SIM) 
 
Based on his experience overseas, a US-based pharmacist, who formerly worked in the UK, 
highlighted how the health system in the US presently utilises the skills and takes advantage 
of the accessibility of community pharmacists in the delivery of public health services, 
The pharmacy is always the first point of call … something like flu, pneumonia, or the 
childhood immunisations … Pharmacists are now immunising, because they have a 
far wider reach of the public … they do not necessarily need to make an 
appointment to see the pharmacist (USP-CHD). 
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Empowerment through direct remuneration of pharmacists 
According to another participant, remunerating pharmacists directly rather than through 
their employers for providing public health services could be an incentive for pharmacists to 
play greater role in public health services, 
So, whoever is acting in the capacity of the function for today is taking responsibility 
for every aspect of public health … they should be remunerated accordingly and not 
the business …there are many, many roles the pharmacists can do, if value is place 
on them to do it (P-OL). 
 
The use of new technologies and social media in practice 
On the use of new technologies in public health, one nurse practitioner saw this as an 
avenue through which community pharmacists could attract the younger population who is 
often hard to reach. In the case of another participant, the use of new technologies is likely 
to be innovative and beneficial for the promotion of public health campaigns. One of our 
participants talked about the use of popular applications such as Twitter, Instant Messaging 
and Facebook in public health activities, 
We are living in such a technologically advanced world, everything is online, and 
everything is on Twitter or Facebook or whatever. I think if we can utilise that in 
some way for pharmacists that will be great (P-NKT). 
 
One participant described other situations where the use of new technologies could help 
enhance the public health role of community pharmacists, for example, for recording the 
public health activities offered by community pharmacies, which could also be useful in 
emergency situations. For another participant, new technologies could also be extended to 
other areas, such as the Medicines Use Reviews (MURs) in patients’ homes, which could 
then be linked to the GP practice computers (and maybe the computers at the pharmacy 
and hospital). A GP participant argued that doing otherwise could amount to a waste of 
resources, 
Giving advice could be a waste of resources when the person can easily contact you 
through Telehealth … It will be invaluable. You take photos, and say, 'I got this rash, 
what do you think? Do you think I should see my GP?' That will help (GP-CHY). 
 
6 
 
On specific technologies, some of the suggestions included: the development of diagnostic 
tools to quickly differentiate bacterial and viral infections, using the Electronic Prescription 
Service (EPS 2) system, telephone and smart phone systems, and social media applications 
such as the Smart Messaging Service (SMS), Twitter and Facebook. One participant 
suggested the use of robots in dispensing. 
Teaching the use of new technologies 
Regarding the teaching of using new technologies for public health/pharmacy practice in UK 
pharmacy schools, most of our interviewees indicated that they were happy with this 
arrangement, even in situations where the same participants had earlier shown some 
reservation on their use in practice. According to one participant, 
It would really go a long way to open their mind sets, to understanding how practical 
it is, how a pharmacy is actually run. But unfortunately, what we actually see in most 
pharmacy schools today is the opposite of how a pharmacy and new technologies 
are being run (P-VI). 
 
Yet, for two other participants, it seemed logical, bearing in mind that the pharmacists of 
today will have no choice but to face the challenges of the computer age, 
Obviously, as we advance it seems like the computer is here to stay and the robot is 
here to stay. So, definitely, it needs to be on the curriculum GP-NA) 
 
 
People need to know, because when they qualify they can't escape new technologies 
(P-SOL). 
 
While one of our participants was against the use of new technologies in pharmacy practice, 
probably due to an earlier negative experience he had had with robots, he did not believe 
that this should prevent UK pharmacy schools teaching students about their use, his 
reasoning being that it is the responsibility of universities to ensure they provide sound 
education to their students. Interestingly, the tendency of older professionals to be less 
interested in the use of new technologies in practice was also captured in the responses of 
another participant: 
You know some pharmacists who graduated many years ago, they may not be all 
that interested in handling these machines, so it has to be a kind of organising 
workshop that would help many pharmacists to have that technological know-how 
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in handling these new technologies (P-PK). 
 
Some of the benefits of enhancing the public health role of community pharmacists 
Enhancing preventative care 
The main benefit of pharmacists’ involvement in the public health role could be in the area 
of preventative care. This benefit was reported to be not only for pharmacists, but also for 
every healthcare professional, 
I think there is a benefit … not just for pharmacists, but for every healthcare 
professional to be involved in public health because it is a preventative measure. 
Why give people statins, when you can start by just educating them about health, 
about exercise, about not smoking? (PR-FLY) 
 
Supporting this, another participant argued that this was not just about treatment; it was 
also about preventing long-term diseases, which could then save lives through lifestyle 
changes, etc. 
So trying build up in such areas as epidemiology or statistics or something like that, 
could be one of the best things to put into the curriculum of pharmacy education, so 
that they could try to spot it out as quickly as possible … You could be part of the 
global team necessary to enhance global health (P-JO). 
 
Enhancing accessibility 
Another benefit relates to accessibility, particularly, as this will enable community 
pharmacists to be more trusted and respected by the public. 
Yeah, there are benefits, definitely. The benefits, I would say, will include the fact 
that community pharmacists are in regular contact with a wide majority of members 
of the community – that is the greatest benefit (P-PO). 
 
Enhancing collaboration 
For some, enhancing the public health role of community pharmacists could encourage 
collaboration between pharmacists and other healthcare professionals, enhance the profile 
of pharmacists, and extend their role in healthcare delivery. This might also mean less 
pressure on GPs over matters that could easily be resolved by pharmacists, 
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Saves you listening to coughs and colds every minute! Every minute, coughs and 
colds coming to me, you know, when the pharmacist can just give advice for that 
(GP-CHY). 
 
Financial savings and time management 
For others, the benefits could be in the area of financial savings to the NHS, enhancing the 
viability of community pharmacies and improving time management for other healthcare 
providers. 
The use of Independent Pharmacist Practitioners (IPPs) 
According to a GP interviewed, the use of independent GP practitioners in general practice 
is a common feature, hence, she saw no reason why this group of practitioners could not be 
useful in community pharmacy public health activities, 
But they are pharmacists? Aren’t they?… It's just like for us doctors, not everybody is 
affiliated to a practice … but, when they need us, because they know where we are, 
we go and help them out. So, in the same way, if there is a list of IPPs… Like right 
now, I'm not affiliated anywhere (GP-CHY). 
 
On the other hand, one of our participants raised the issue of ‘ownership’ of public health 
qualifications, which, he reasoned, often belong to the practitioner rather than the practice, 
and hence, places independent pharmacist practitioners at the centre of public health services. 
Using the recent Ebola outbreak in West Africa as an example, another participant described 
IPPs as ‘stakeholders in public health’, particularly as in this case, IPPs (not pharmacies) had 
to work collaboratively with other practitioners to contain the situation. However, this 
participant cited another example, on the global Vitamin D deficiency that, he argued, could 
also be tackled by IPPs, hence, the need for pharmacists to take up leadership positions in 
public health. The advantage of this model, reasoned another participant, lies in the fact 
that practitioners will be practising for the benefit of patients rather being constrained by 
some of the limitations associated with commercially oriented establishments, 
I think that could intentionally be a good thing because, hopefully, they are actually 
working for the benefit of the patient, as opposed to maybe some sort of business 
(HP/TP-NKT). 
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Teaching communication methods to students and pharmacists 
On the teaching of communication methods to UK pharmacy students and pharmacists, all 
of our participants agreed that this could enhance the role of community pharmacists in 
public health. A preregistration participant argued that this could help students and 
pharmacists develop skills in the use of pharmacy consultation tools (mnemonics) in 
practice. A GP participant also supported this, 
The communication method is very important, just like saying bedside manner. Isn't 
it, of a doctor? … They talked to us about communication skills as doctors; that we 
need to be empathetic … a need for confidentiality. And communication methods 
are very important, because you're looking at people from all kinds of lives, religions, 
beliefs (GP-CHY). 
 
Other benefits lie with the ability to provide patients with information on the use of medical 
equipment and devices. Yet the teaching of communication methods could help develop 
some uniformity across healthcare professions, particularly in terms of service delivery and 
information provision; it could help pharmacists consolidate public health messages from 
other healthcare practitioners, as well as to help enhance the profile of pharmacists, 
Because, some patients come to the pharmacy, not with a lot of confidence, it's after 
you interact with them that they begin to respect you and value you (P-OL). 
 
Sometimes, you find in general practice that you give a patient advice on how to do 
something, how to take a particular medication and how to self-manage, and they 
forget it when they go out of the door (GP-NN). 
 
Integrating UK undergraduate healthcare programmes 
 
On the question that asked if UK pharmacy students should be taught with other health 
students, e.g. medical and nursing students, the majority of participants indicated that this 
was a good idea. Obviously, this would help break down barriers and facilitate 
communication between healthcare practitioners, as well as foster a better understanding 
of the roles and skill sets of practitioners. In addition, it could widen the professional field of 
pharmacists, enhance their knowledge base, and improve their ability to pass information 
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on easily. Furthermore, as some of the modules taught to students are health related, many 
of them could be taught at the same time across professions, 
So, it is good for all to understand what the physiotherapist does, what the special 
nurse does, what they do, how to communicate … Even professions have got their 
own sense of pride … Doctors see us in a certain way and pharmacists, so it's all good 
to get that, even during education, so that when it happens in the real world, it 
doesn't get you by surprise (PR-FLY). 
 
 
A line of thought also supported by a GP participant, 
It will help because, especially when you're dealing with chronic conditions …you 
know, a chronic condition is a drain in healthcare in this country … we are not 
intertwined with other people who are also health professionals, who play an 
important part. And then when you get to working with them, you have no clue how 
to handle them; so taking certain courses together will help (GP-CHY). 
 
Another participant also supported this, based on his experience both as an undergraduate 
pharmacy student and as a PhD student in two developed countries. 
And if you look at a number of countries, medical schools and pharmacy schools are 
together … you find that the basic subjects both parties need to know are always 
taught together in one class … I had background training which I spent together with 
medical students and dentists, … then we separated to different lines. So, you have a 
basic understanding of what a pharmacist knows, what that the doctor is aware of, 
or that the dentist is aware … When there is a common problem, we could all be 
speaking on the same wavelength, rather than what you find at times in this country, 
they (pharmacists) are not even confident to speak to doctors … In some areas, 
doctors don't even know what the role of a pharmacist is! (P-JO). 
 
Another participant, a GP, also supported this idea of integrated training, having witnessed 
a similar experience overseas. 
I think it is a fantastic idea … I'm not sure if it happens here. If not, why not? I think 
it's important that we have collaboration among the different health professionals. I 
think training together is a good way to use resources, lecturer time, equipment, lab 
time, and even the building … You just have one school for health professionals in an 
area or town or region or county … The way I trained, that's the model I'm familiar 
with, and I think it works quiet well. I have no problems with this type of thing, as it 
is actually a good idea, so it's efficient, it offers savings, it works well because when 
everyone is fully qualified in different spheres you are better able to cooperate 
because you’re coming from professions where some of you have relationships, 
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which develop people on a personal level and that obviously helps when you are 
working together as a team (GP-NN). 
 
In terms of organisation, several subjects including pharmacology could benefit, 
You do your degree in pharmacy, not in the same building as somebody who is a 
medical student. But they could definitely go to the same lectures. There is no 
reason why not. Some lectures in pharmacology would be possible, if they were able 
to organise it (GP Partner-SIM). 
 
Additional benefits 
As well as the benefits highlighted above, we learnt that integrated learning would enable 
practitioners to understand the rationale behind unfamiliar concepts, such as off-licence 
prescribing, as well as to appreciate the behaviour of healthcare colleagues. In addition, 
integrated learning could facilitate patients’ care services. This could also provide an 
opportunity to further enhance the knowledge base of undergraduate students, as 
integrated training would enable students to ask questions of other healthcare students 
from their perspective, something that might never be possible through unitary training. 
Yet, integrated training could help reduce any negative perceptions doctors might have that 
pharmacists are ‘clamouring for their jobs’. 
 
Pharmacists working with other healthcare practitioners 
According to one of our respondents, pharmacists working alongside other healthcare 
professionals would enable a holistic management of patients to develop, without which 
another respondent argued, the whole idea of patient care becomes counterproductive, 
Pharmacists do not operate in a silo-environment … Pharmacists cannot work 
independent of other members of the health team … such a module is 
counterproductive to the person and patients who are asking for quality services (P-
ART). 
 
Furthermore, a nurse participant argued that pharmacists working alongside other 
healthcare professionals could be the way forward for the NHS, particularly as it would help 
reduce waiting times and prevent harm to patients due to unintended prescribing errors. 
Nonetheless, building patients’ confidence in the pharmacist through proper education is 
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important. According to a GP practitioner, this type of integration is best achieved when 
healthcare professionals have been trained together during undergraduate training. Other 
than managing health outcomes, another participant reported that integrated work 
patterns could also help pharmacists access better career progression and fulfilment in 
practice. 
 
According to one of our participants, GP practices that employed pharmacists seemed to 
make fewer prescribing errors than other practices. Her reasons were that in-house 
pharmacists were able to correct any errors before prescriptions leave the practice. In 
addition, these GP practices were also more likely to follow the National Institute for Clinical 
Excellence (NICE) guidance in their prescribing patterns, hence, helping to minimise harm to 
patients. Moreover, they were also more likely to consider the cost of medicines and other 
items in their prescribing habits, which can translate to a lot of savings to GP practices and 
the wider NHS. Pharmacists employed in GP practices, particularly those with sound clinical 
knowledge and skills, she further argued, were often in a better position to advise doctors 
regarding the best therapeutic choices in complex clinical. However, not all practices are 
able to employ in-house pharmacists due to financial constraints, 
So, I think, that’s how every surgery should be run, to have a pharmacist inside the 
surgery advising a group of doctors …Because a lot of them don't know which drug is 
expensive, which one is not, they just follow whatever information was sent to them, 
maybe, by the Clinical Commissioning Groups (CCGs)… But people always think that 
pharmacists are expensive (P-SOL). 
 
Hopefully, the recent Royal Pharmaceutical Society’s and the Royal College of General 
Practitioner's integrated practice, which is being developed with the support of the 
government20,21 will help move this initiative forward. 
 
Changing the curriculum to increase its public health content 
On changing the UK undergraduate pharmacy curriculum to increase its public health 
content, our preregistration pharmacist participant argued that many of the common 
chronic conditions we find today are interlinked with lifestyles. Hence, there is a need to 
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enhance both public health knowledge as well as the collaborative skills of healthcare 
professionals. This will also entail spending money on the public health education of 
healthcare professionals as a preventative measure, rather than on certain therapeutic 
medicines. Another participant emphasised the need to ensure that undergraduate 
pharmacy students were well informed about public health before graduation, which could 
then be augmented, depending on individual needs, 
It will be important that before a pharmacist graduate goes into community 
pharmacy, as a pharmacist, that they're aware of public health as a discipline … 
depending on what services they provide in their areas, further training can always 
be provided (P-PO). 
 
It also seems that broadening the public health knowledge of pharmacists would help 
extend their role in public health, particularly when this is supported by education, 
increased awareness and the NHS triage system. 
At the moment now, most pharmacists … they just give you your usual supply of 
prescription. They don't advise anymore. This year we have started giving leaflets to 
patients. So when we triage, we give them leaflets. Basically, they say that you don't 
need to come to A&E for every simple minor cold and flu. You can get over-the-
counter medication from the pharmacy. It is about educating the public that even 
your flu, whatever, you can still get drugs from the pharmacist without the need to 
pay (N-CHM). 
 
One of our participants further argued that changing the undergraduate pharmacy 
curriculum could also help students and pharmacists keep abreast of the ever-changing 
healthcare structure in the UK. However, the onus lies with pharmacists remaining up to 
date with these changes. Supporting the need for change, another participant wanted this 
to be in the area of public health information. On the type of change needed, another 
participant indicated that he was not happy with the dominance of science modules in the 
present UK undergraduate pharmacy curriculum, at the expense of strong public health 
content. He would prefer the public health module in UK pharmacy schools to be exactly the 
same as found in many medical schools. 
It should be the same in pharmacy schools as medical schools. There is a need to 
incorporate public health as a major part of pharmacy curriculum … There are some 
things that might need to be reduced if there is need for it, like the pharmacist is 
trained to be an industrialist, at the same time, a public health worker … The 
pharmacy curriculum includes a lot of scientific training, as to discovery, invention of 
medications, drug development, drug design, and all of that. While those are 
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important, there is also a need to bring in a strong public health curriculum, which is 
the way the practice is going (P-OL). 
 
Supporting this line of thought, another participant argued that, 
 
It is not good if you're not clinically sound when you're qualified as a pharmacist: 
that you just have to be learning all these things as you go along … Whatever they 
are teaching them in clinical pharmacy in the hospital, I think it should be brought 
into the university syllabus, so that when people leave they know all these things. 
When I was in the final year, people had to choose whether they wanted to do 
chemistry, whether they wanted to do pharmacology…people had different options. 
To me, I think that's a waste of time … I think I did chemistry and biochemistry and I 
can't remember needing this after I left the university - using that chemistry (P-SOL). 
 
There was also the issue of the lack of a basic health infrastructure in some of the 
consultation rooms located in community pharmacies, e.g. the absence of comfortable 
waiting areas and the continued over-emphasis by pharmacy owners, most of whom are 
non-pharmacists, on profit and the steady growth of the business. 
You must have a consultation room; all we need to do now is to give parameters for 
a consultation room in terms of dimension, in terms of what should be there … they 
are not thinking about what they have provided for you to enhance (help) the 
patient. Even the books they are providing, this is because registration makes it 
compulsory for them to provide them, otherwise, they would cut them as cost 
savings … Then, there must be a waiting area as well, for your customers … where 
people can speak and be comfortable (P-OL). 
 
Finally, the global nature of pharmacy practice is another reason why there is a need to 
change the undergraduate pharmacy curriculum, and this might also mean adopting good 
practices from other systems. 
 
Discussion 
This project has enabled us to identify some of the strategies needed to enhance the public 
health role of community pharmacists in the UK. Particularly in relation to dual medical 
degrees, while not popular in the UK (except with medical degrees) their popularity and take 
up has increased considerably in the US in the last decade or so.22 A number of papers have 
discussed how the introduction of the dual pharmacy degree in the UK could empower and 
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create jobs for pharmacists, particularly at a time when the profession is struggling with an 
over-supply of pharmacists.23,24 
On the use of new technologies and social media in practice, another paper has described 
how the clinical as well as the public health role of community pharmacists could be 
enhanced (with the added benefit of financial savings), through the use of new technologies 
that allow pharmacists to give advice to patients at a distance with the help of a webcam, a 
computer and a broadband Internet connection.25 In support of this, another paper26 has 
also argued that social networks can be great tools for accessing professional knowledge 
and disseminating information globally. While our interview participants were, in general, 
supportive of the use of new technologies and social media in practice (also bearing in mind 
the needs of younger service users), a few of them, particularly the older practitioners, were 
less supportive. Some of their concerns centred on privacy and confidentiality and their 
belief that patient care was best delivered through face-to-face contact. Our elderly GP 
Partner participant even argued that the use of new technologies was a waste of resources. 
However, the public health role of community pharmacists could be affected by the fact 
that many UK pharmacy schools are failing to match theory with practice. To enhance the 
public health role of community pharmacists in the UK there is, therefore, a need to engage 
more than one pharmacist in community pharmacies during opening hours. A GP Partner 
[SIM] and a pharmacist participant [PKT] were fully in support of this when interviewed. One 
of our interviewees argued that all the chemistry she learnt during her undergraduate 
pharmacy training in the 1990s had made little contribution to her practice as a community 
pharmacist. It seems that UK pharmacy schools shifting their emphasis from the basic 
sciences to more clinical and public health topics might be more relevant to pharmacists in 
their clinical as well as their public health roles. However, the UK system, where most 
students have little or no interaction with other healthcare students at undergraduate level, 
remains a deviation from the experience of some of our interview participants who had 
witnessed some of the benefits of integrated training overseas. 
 
A number of our interview participants hinted that they would like pharmacists to enhance 
patients' self-management capacities. Again, from the comments we received from our US-
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based pharmacist participant, it seems reasonable to argue that the NHS could learn a few 
things from the practices of US health insurance companies, which seem to minimise the 
need to make huge treatment payouts by paying community pharmacies/pharmacists to 
provide immunisation services to patients. Even within the UK non-health sector, several 
insurance and utility companies are known to offer online self-care tips, which they hope 
will help reduce their costs by limiting the need for customer call-outs. 
Although, some of our interview participants made general statements regarding the use of 
medicines, none of them raised any specific issues concerning polypharmacy. In Scotland, 
the Scottish government supports pharmacists’ enhanced role in polypharmacy to minimise 
risks to patients.27 To support this and other community pharmacy initiatives, the Scottish 
government has also noted that remunerating pharmacists directly for providing public 
health services can help enhance their role in public health.28 
Enabling the development of IPPs who are not attached to employers, as proposed by a 
pharmacist organisation,29 could help change the status quo and, at the same time, 
motivate pharmacists to enhance their role in public health.30 Another benefit of this model 
is that it limits some of the constraints often associated with employer-led public health 
services, such as targets and other commercial considerations.29,31 While the pharmacist’s 
prescribing role is becoming an important element of pharmacy practice,32,33 none of the  
interview participants showed any desire to see UK pharmacists developing their skills in 
this area. 
 
Recommendation for further studies 
Our findings could be made more illuminating by exploring the perspectives of healthcare 
users. None of our interview participants highlighted the need for a dual pharmacy degree 
in the UK. On the use of new technologies and social media, our older interview participants 
were less interested in their use in community pharmacy practice. Further researcher on the 
need for a dual pharmacy degree and the use of new technologies and social media in the 
UK might be needed to identify how these could help enhance the public health role of 
community pharmacists. 
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Limitations 
Some of the issues raised in the interviews with healthcare professionals might be a 
reflection of interviewees’ pressing concerns at the time of data collection.34 Prior 
knowledge of some of the respondents’ professions may have affected both the issues 
raised35 and the respondent’s willingness to share certain views.36 
 
Conclusions 
This study has identified a range of strategies that could potentially enhance the public 
health role of community pharmacists in the UK. Enhancing the public health role of 
community pharmacists could make services more accessible to the public, increase public 
safety and trust in pharmacists, encourage collaboration between pharmacists, doctors and 
other healthcare providers, and bring financial savings to the NHS. In addition, developing 
the public health role of community pharmacists could help reduce stress levels among 
other healthcare professionals, as well as empower and guarantee the status of community 
pharmacists as important members of the healthcare team. 
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